Written question asked by Jim Shannon (Democratic Unionist Party) on Tuesday, 16 December 2025, in the House of Commons. It was due for an answer on Thursday, 18 December 2025. It was answered by Ashley Dalton (Labour) on Wednesday, 14 January 2026 on behalf of the Department of Health and Social Care.
Prostate Cancer: Screening
- Question
-
To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of levels of access to PSMA PET-CT imaging on regional and ethnic inequalities in prostate cancer diagnosis and outcomes.
- Answer
-
The Department recognises that access to PSMA PET-CT imaging varies across England and that this may exacerbate existing disparities.
NHS England has introduced a commissioning policy for PSMA PET-CT imaging for patients with high-risk or recurrent prostate cancer, and work is underway to expand capacity and improve resilience in diagnostic services
Tackling health inequalities remains a core priority. Through the Core20PLUS5 framework, NHS England is working to reduce disparities in cancer outcomes. The forthcoming National Cancer Plan will set out further actions to improve early diagnosis and equitable access to cancer services across England.
Secondary information
- Type
- Written question
- Reference
- 100315
- Session
- 2024-26
- Subjects
- Access Diagnosis Equality Ethnic groups Prostate cancer Screening
- Link
- View this Written question on www.parliament.uk
Librarians' tools
- Timestamp
- 2026-01-14 15:36:50 +0000
- URI
- http://data.parliament.uk/writtenparliamentaryquestion/commons/2024-26/100315
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/writtenparliamentaryquestion/commons/2024-26/100315
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/writtenparliamentaryquestion/commons/2024-26/100315